학술논문

Fulvestrant plus capivasertib for metastatic breast cancer – Authors' reply
Document Type
Correspondence
Source
In The Lancet Oncology May 2020 21(5):e234-e234
Subject
Analysis and Interpretation
Correspondence
Language
ISSN
1470-2045